2026paź
SOLV Oct 2026 · Buy
Solventum Corporation (NYSE: SOLV) is rated Buy with a house fair value of $103.66 per share, offering an implied upside of 19.75% from its October 14, 2026 price of $86.57. While near-term reported revenues absorb ERP cutover order shifts and SKU rationalization, core surgical consumable volumes and strategic portfolio separation provide robust compounding potential.Latest published research · analyzed 2026-10-14 · current · sources aging